TY - JOUR
T1 - Structure, Function, and Therapeutic Potential of the Trefoil Factor Family in the Gastrointestinal Tract
AU - Braga Emidio, Nayara
AU - Brierley, Stuart M.
AU - Schroeder, Christina I.
AU - Muttenthaler, Markus
PY - 2020/8/14
Y1 - 2020/8/14
N2 - Trefoil factor family peptides (TFF1, TFF2, and TFF3) are key players in protecting, maintaining, and repairing the gastrointestinal tract. Accordingly, they have the therapeutic potential to treat and prevent a variety of gastrointestinal disorders associated with mucosal damage. TFF peptides share a conserved motif, including three disulfide bonds that stabilize a well-defined three-loop-structure reminiscent of a trefoil. Although multiple functions have been described for TFF peptides, their mechanisms at the molecular level remain poorly understood. This review presents the status quo of TFF research relating to gastrointestinal disorders. Putative TFF receptors and protein partners are described and critically evaluated. The therapeutic potential of these peptides in gastrointestinal disorders where altered mucosal biology plays a crucial role in the underlying etiology is discussed. Finally, areas of investigation that require further research are addressed. Thus, this review provides a comprehensive update on TFF literature as well as guidance toward future research to better understand this peptide family and its therapeutic potential for the treatment of gastrointestinal disorders.
AB - Trefoil factor family peptides (TFF1, TFF2, and TFF3) are key players in protecting, maintaining, and repairing the gastrointestinal tract. Accordingly, they have the therapeutic potential to treat and prevent a variety of gastrointestinal disorders associated with mucosal damage. TFF peptides share a conserved motif, including three disulfide bonds that stabilize a well-defined three-loop-structure reminiscent of a trefoil. Although multiple functions have been described for TFF peptides, their mechanisms at the molecular level remain poorly understood. This review presents the status quo of TFF research relating to gastrointestinal disorders. Putative TFF receptors and protein partners are described and critically evaluated. The therapeutic potential of these peptides in gastrointestinal disorders where altered mucosal biology plays a crucial role in the underlying etiology is discussed. Finally, areas of investigation that require further research are addressed. Thus, this review provides a comprehensive update on TFF literature as well as guidance toward future research to better understand this peptide family and its therapeutic potential for the treatment of gastrointestinal disorders.
KW - epithelial wound healing
KW - gastrointestinal disorders
KW - mucosal protection
KW - peptide drug development
KW - TFF1
KW - TFF2
KW - TFF3
KW - trefoil factor family
UR - http://www.scopus.com/inward/record.url?scp=85090936216&partnerID=8YFLogxK
UR - http://purl.org/au-research/grants/NHMRC/1126378
UR - http://purl.org/au-research/grants/NHMRC/1139366
UR - http://purl.org/au-research/grants/NHMRC/1140297
UR - http://purl.org/au-research/grants/NHMRC/1156427
UR - http://purl.org/au-research/grants/ARC/DP180101395
U2 - 10.1021/acsptsci.0c00023
DO - 10.1021/acsptsci.0c00023
M3 - Review article
AN - SCOPUS:85090936216
SN - 2575-9108
VL - 3
SP - 583
EP - 597
JO - ACS Pharmacology and Translational Science
JF - ACS Pharmacology and Translational Science
IS - 4
ER -